Deucrictibant Provides Rapid Relief for Hereditary Angioedema Attack Symptoms

A new oral medication has demonstrated remarkable effectiveness in treating hereditary angioedema (HAE) attacks, offering patients significantly faster symptom relief compared to existing options. According to Healio.com, the RAPIDe-3 study…

Continue Reading Deucrictibant Provides Rapid Relief for Hereditary Angioedema Attack Symptoms

Oral Treatment Revolution: BioCryst Transforms Pediatric Hereditary Angioedema Care with New FDA-Approved Formulation

For decades, children battling hereditary angioedema (HAE) faced a challenging reality: preventing life-threatening angioedema attacks meant enduring regular intravenous infusions or subcutaneous injections. This barrier to preventive care has now…

Continue Reading Oral Treatment Revolution: BioCryst Transforms Pediatric Hereditary Angioedema Care with New FDA-Approved Formulation

HAEi’s HAE Global Conference

  • Post author:
  • Post category:

The 2018 HAE Global Conference "Take control of your HAE" #haeGC18 The event will be an opportunity for caregivers, researchers, scientists, and the international hereditary angiodema patient community to converge…

Continue Reading HAEi’s HAE Global Conference
Living with Hereditary Angiodema: My Life was Changed in an Instant, Part One
Source: Loukisha Olive-McCoy

Living with Hereditary Angiodema: My Life was Changed in an Instant, Part One

From birth until my mid-thirties I was a very active person. I loved dancing West Coast Swing, doing yoga, and cooking large meals for my ‘Ohana. The word "'Ohana" describes…

Continue Reading Living with Hereditary Angiodema: My Life was Changed in an Instant, Part One
Treatment for Hereditary Angiodema Gets Marketing Approval From the EMA
source: pixabay.com

Treatment for Hereditary Angiodema Gets Marketing Approval From the EMA

According to a recent story from pm360online.com, the pharmaceutical company Shire announced that the marketing application for its drug product lanadelumab has gained approval from the European Medicines Agency (EMA).…

Continue Reading Treatment for Hereditary Angiodema Gets Marketing Approval From the EMA